EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study

Cecilia Becattini, Giancarlo Agnelli, Aldo P Maggioni, Francesco Dentali iD, Andrea Fabbri, Iolanda Enea, Fulvio Pomero, Maria Pia Ruggieri, Andrea di Lenarda, Ludovica Anna Cimini, Giuseppe Pepe, Susanna Cozzio und 3 weitere

Thrombosis and Haemostasis · 2023-06 · 123 (06) · 613-626

DOI: 10.1055/a-2031-3859 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 20.03.2023. Verfasst von Cecilia Becattini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Internal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Pulmonary Embolism. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daiichi-Sankyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolism (PE) leading to changes in clinical practice and potentially influencing short-term patients' outcomes. Research question The COntemporary management of PE (COPE) study is aimed at assessing the contemporary clinical management and outcomes in patients with acute symptomatic PE. Study Design and Methods Prospective, noninterventional, multicenter study. The co-primary study outcomes, in-hospital and 30-day death, were reported overall and by risk categories according to the European Society of Cardiology (ESC) and American Heart Association guidelines.

Results

Among 5,213 study patients, PE was confirmed by computed tomography in 96.3%. In-hospital, 289 patients underwent reperfusion (5.5%), 92.1% received parenteral anticoagulants; at discharge, 75.6% received direct oral anticoagulants and 6.7% vitamin K antagonists. In-hospital and 30-day mortalities were 3.4 and 4.8%, respectively. In-hospital death occurred in 20.3% high-risk patients (n = 177), in 4.0% intermediate-risk patients (n = 3,281), and in 0.5% low-risk patients (n = 1,702) according to ESC guidelines. Further stratification in intermediate-high and intermediate-low risk patients did not reach statistical significance, but intermediate-risk patients with sPESI > 0 alone had lower mortality compared to those with one or both among right ventricular dilation at echocardiography or increased troponin. Death or clinical deterioration occurred in 1.5, 5.0, and 9.4% of patients at low, intermediate-low, and intermediate-high risk for death according to ESC guidelines.

Conclusion

For the majority of patients with PE, contemporary initial management includes risk stratification and treatment with direct oral anticoagulants. In-hospital mortality remains high in intermediate and high-risk patients calling for and informing research focused on its reduction. Trial Registration number: NCT03631810.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismHumansPrognosisProspective StudiesHospital MortalityAnticoagulantsAcute DiseaseDisease ProgressionRisk Assessment

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Internal, Vascular and Emergency Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
  • ANMCO Research Center, Heart Care Foundation, Florence, Italy.
  • Department of Clinical and Experimental Medicine, Insubria University, Varese, Italy.
  • Emergency Department, "Presidio Ospedaliero Morgagni-Pierantoni," Forlì, Italy.
  • U.O.C. Medicina e Chirurgia d'Urgenza, A.O.R.N. "S. Anna e S. Sebastiano," Caserta, Italy.
  • Division of Internal Medicine, Michele and Pietro Ferrero Hospital, Verduno, Italy.

ORCID-Profile: Francesco Dentali

Förderung

  • Daiichi-Sankyo

Zitieren

APA

Becattini, C., Agnelli, G., Maggioni, A. P., Dentali, F., Fabbri, A., Enea, I., Pomero, F., Ruggieri, M. P., di Lenarda, A., Cimini, L. A., Pepe, G., Cozzio, S., Lucci, D., Gulizia, M. M., & COPE Investigators (2023). Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study. Thrombosis and Haemostasis, 123(06), 613-626. https://doi.org/10.1055/a-2031-3859

Vancouver

Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, et al. Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study. Thrombosis and Haemostasis. 2023;123(06):613-626. doi:10.1055/a-2031-3859

BibTeX
@article{Becattini2023,
  author = {Becattini, Cecilia and Agnelli, Giancarlo and Maggioni, Aldo P and Dentali, Francesco and Fabbri, Andrea and Enea, Iolanda and Pomero, Fulvio and Ruggieri, Maria Pia and di Lenarda, Andrea and Cimini, Ludovica Anna and Pepe, Giuseppe and Cozzio, Susanna and Lucci, Donata and Gulizia, Michele M and COPE Investigators, COPE Investigators},
  title = {Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study},
  journal = {Thrombosis and Haemostasis},
  year = {2023},
  volume = {123},
  number = {06},
  pages = {613--626},
  doi = {10.1055/a-2031-3859}
}
Kostenlos starten →